Rankings
▼
Calendar
NERV FY 2015 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
NERV
Minerva Neurosciences, Inc.
$52M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$17,276
Operating Income
-$26M
Net Income
-$27M
EPS (Diluted)
$-9.25
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$24M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$83M
Total Liabilities
$27M
Stockholders' Equity
$55M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$17,276
$0
—
Operating Income
-$26M
-$55M
+52.4%
Net Income
-$27M
-$57M
+52.4%
← FY 2014
All Quarters
Q4 2015 →